Skip to content
Screener

Total Revenue at other companies

Baxter International logo
Baxter InternationalBAX
$2.7B+2.9%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$4.98B-9.5%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$34.17M
Embecta Corp. logo
Embecta Corp.EMBC
$271.7M-8.1%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$33.68M-3.0%
UFP Technologies logo
UFP TechnologiesUFPT
$173.96M+15.1%

Segments

By geography

See full
US$8.01M

Other financials

Income statement

See full
Gross profit$7.8M+21.2%
Operating income$627.0K+301%
Net income$252.4K+222%
EPS (diluted)$0.01

Balance sheet

See full
Cash & equivalents$8.3M+2.9%
Total debt$3.5M-0.3%
Total equity$18.1M+9.2%
Total assets$28.0M+9.6%

Cash flow

See full
Operating cash flow$216.1K+147%
CapEx$107.9K+274%
Free cash flow$108.2K+122%

Valuation

See full
Market cap$148.21M-24.6%
Enterprise value$143.38M-25.3%
P/S3.3×-2.0×

Profitability

See full
Gross margin62.4%-0.7pp
Operating margin-3.7%-1.5pp
Net margin-4%-1.6pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-10.5%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.7×-0.2×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: KORU Medical Systems’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:08 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q3 2026
Accession
0001161697-26-000189
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
NET REVENUES$12,045,420$10,194,800$23,810,044$19,829,875
Cost of goods sold4,199,2123,719,0318,732,4477,307,771
Gross Profit7,846,2086,475,76915,077,59712,522,104
OPERATING EXPENSES
Selling, general and administrative5,939,9865,384,14812,522,16511,343,522
Research and development1,069,2001,194,7892,385,8042,309,398
Depreciation and amortization210,031209,487407,561426,844
Total Operating Expenses7,219,2176,788,42415,315,53014,079,764

Item 1. Condensed Financial Statements (Unaudited) Item 1. Financial Statements (Unaudited)

FAQ

What is KORU Medical Systems's total revenue?
KORU Medical Systems (KRMD) reported total revenue of $12.05M in Q2 2026.
How has KORU Medical Systems's total revenue changed year-over-year?
KORU Medical Systems's total revenue increased by 18.2% year-over-year, from $10.19M to $12.05M.
What is the long-term trend for KORU Medical Systems's total revenue?
Over 4 years (2021 to 2025), KORU Medical Systems's total revenue has grown at a 15.0% compound annual growth rate (CAGR), from $23.49M to $41.13M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about KORU Medical Systems's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude